Dindolyl Methane, or DIM as it’s commonly known as, is a well-known supplement for bodybuilders as well as others who are interested in increasing the growth of their muscles. Recent research has shown that DIM could pose health hazards. DIM can cause liver damage if taken in excessive amounts. Another risk is kidney damage, which could lead to kidney failure. The long-term health risks of DIM make many bodybuilders and athletes ask the question: should I supplement my diet with a supplement with DIM?
To increase testosterone production, most people take a diindolylmethane supplemental. It is well-known that testosterone acts as an androgen. This means that it can trigger hormonal changes within the tissues. Research has shown DIM to mimic the effects both of testosterone and other hormones. Since men produce more testosterone than women do Certain manufacturers have added diindolylmethane into their products in order to boost their competitiveness in male circles. Men will respond to products that are similar to testosterone that is naturally produced.
Many companies advertise DIM as a tumor suppressor. It’s true that diindolylmethane does reduce the growth of tumors in laboratory animals, however the animals were administered the drug, not administered orally. To achieve the same result in humans, diindolylmethane has to be consumed in large doses over a prolonged period of time. The animals that were examined did not show signs of cancer for many years. However, they all developed liver diseases after consuming excessive amounts of diindolylmethane. For a thorough understanding of how DIM works in the body, you should seek out a medical professional.
The only way to prove that DIM is effective in treating breast carcinoma is to conduct an experiment in which cells from healthy breast cells are exposed to high doses of diindolylmethane over an extended period of time. As with any chemical there are pros and cons associated with using it. Pros include the ability to mimic hormones. This means that you can make insulin, which could stop the proliferation of cancer cells. The cons include the fact diindolylmethane also produces an extremely harmful chemical known as DMSO. Learn more about dim diindolylmethane benefits now.
One of the most common claims made for diindolylmethane as treatment for various health issues is that it functions as a natural, antibacterial, anti-fungal, and anti-cancer agent. The National Institute of Health, through an exhaustive study of supporting data concluded that there was no basis for these claims. According to the Institute of Chemical Technology there was no evidence from any research that support this claim. In a comprehensive examination of the safety profile of the firestone, the Institute of Chemical Safety concluded that the evidence provided by pharmaceutical companies on the benefits for humans of diindolylmethane was not reliable.
Van der Goes, et. and. published their findings in a May 2021 issue of the Journal of Toxicology and Environmental Health. pointed out numerous potential hazards related to diindolylmethane’s use such as skin rash, allergic reactions, asthma attacks, dizziness, headaches, and respiratory ailments. They also said that the recommended daily allowance for this chemical is 0.2 milligrams, which is about one 10th of a teaspoon. It is unclear what the concentration is when this chemical is mixed with other substances. This substance isn’t safe since it hasn’t been thoroughly test.
The abstract of the view indicates that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the concept of blocking the intracellular inhibition of pyruvate metabolite by flavenoids, and thereby stopping the accumulation of oxalates within renal tubule cells as well as adenine granulocytes. However, metabiplicate toxicity studies did not present convincing evidence that the consumption of this chemical can cause an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescription drug. According to the FDA the manufacturer of firestone tincture is currently in the process of completing two major clinical trials – one in Europe and the other in the United States.
The view abstract also shows that diindolylmethane’s usage in cancer treatment is based on the principle of inhibiting intracellular inhibition via flavenoids of pyruvate metabolism , and thus stopping the accumulation of adenine and oxalates in renal tubule cells. The drug metabiplicate toxicology studies have not proven that this chemical is able to cause overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA, the manufacturer of firestone tincture is in the process of completing two major trials–one in Europe and one in the United States. According to FDA, the FDA states that the maker of firestone Tincture is currently completing two major trials in Europe as well as one in the United States.